Bank Of Montreal Hille Vax, Inc. Transaction History

Bank Of Montreal

$214 Billion
Q3 2024

A detailed history of Bank Of Montreal transactions in Hille Vax, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 24,304 shares of HLVX stock, worth $45,448. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,304

Holding current value

$45,448

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 13, 2024	BUY	$1.58 - $14.42 $38,400 - $350,463	24,304 New	24,304 $42,000
Q3 2023 Nov 01, 2023	BUY	$11.59 - $16.7 $904,020 - $1.3 Million	78,000 New	78,000 $1.05 Million

Others Institutions Holding HLVX

# of Institutions

Shares Held

36.8M

Call Options Held

Put Options Held

Frazier Life Sciences Management, L.P. Menlo Park, CA

10.6M
Shares

$19.9 Million
1.01% of portfolio
Tang Capital Management LLC San Diego, CA

4.92M
Shares

$9.2 Million
0.74% of portfolio
Black Rock Inc. New York, NY

2.09M
Shares

$3.91 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

1.96M
Shares

$3.66 Million
0.0% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

1.88M
Shares

$3.52 Million
0.06% of portfolio

View Full List

About HilleVax, Inc.

Ticker HLVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,427,200
Market Cap $62.5M
Description
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

More about HLVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account